An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
Vitamin D deficiency (VDD) is independently associated with increased depression risk in patients with chronic kidney disease ...
A new study from Karolinska Institutet shows that severe mental illness is more common in patients with chronic kidney ...
The man had been battling chronic kidney disease for 15 years and had undergone two failed transplants in 2010 and 2012.
Severe mental illnesses such as schizophrenia, bipolar disorder and major depression are 56% more common in people who have chronic kidney disease compared to those who don’t have it, according to a ...
The following is a summary of “Association between triglyceride-glucose index and clinical outcomes among patients with ...
Given the rise in such cases in India, THE WEEK spoke to four patients to discuss the impact chronic kidney disease has had ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
There are several factors that lead to kidney damage and spotting the symptoms of the condition at an early stage can help ...
Novo Nordisk’s OZEMPIC Approval Heat Up the Chronic Kidney Disease Therapeutic Market | DelveInsight
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
A recent study published in the Journal of the American College of Cardiology found that high plasma lipoproteins can cause chronic kidney disease by impairing kidney function. Chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results